These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9223318)

  • 1. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice.
    Patel SD; Cope AP; Congia M; Chen TT; Kim E; Fugger L; Wherrett D; Sonderstrup-McDevitt G
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8082-7. PubMed ID: 9223318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
    Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
    J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
    Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
    Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.
    Ou D; Jonsen LA; Metzger DL; Tingle AJ
    Hum Immunol; 1999 Aug; 60(8):652-64. PubMed ID: 10439311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin.
    Congia M; Patel S; Cope AP; De Virgiliis S; Sønderstrup G
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3833-8. PubMed ID: 9520453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
    Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
    J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexity of human immune response profiles for CD4+ T cell epitopes from the diabetes autoantigen GAD65.
    Masewicz SA; Meldrum N; Gersuk V; Gaur L; Hagopian W; Moriarity L; Nepom GT
    Autoimmunity; 2001; 34(4):231-40. PubMed ID: 11905849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR binding analysis of peptides from islet antigens in IDDM.
    Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
    Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
    Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
    J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.
    Greening JE; Tree TI; Kotowicz KT; van Halteren AG; Roep BO; Klein NJ; Peakman M
    Diabetes; 2003 Mar; 52(3):717-25. PubMed ID: 12606513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.
    Abraham RS; Wen L; Marietta EV; David CS
    J Immunol; 2001 Jan; 166(2):1370-9. PubMed ID: 11145722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals.
    Reijonen H; Elliott JF; van Endert P; Nepom G
    J Immunol; 1999 Aug; 163(3):1674-81. PubMed ID: 10415074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
    Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus.
    Tabata H; Kanai T; Yoshizumi H; Nishiyama S; Fujimoto S; Matsuda I; Yasukawa M; Matsushita S; Nishimura Y
    Hum Immunol; 1998 Sep; 59(9):549-60. PubMed ID: 9757911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.